Predictive value of hematological and inflammatory markers for severity of COVID-19

Introduction and Aim: Coronavirus disease 2019 (COVID–19) can cause damage to a wide variety of organs throughout the body, with lung being its primary focus attack. The identification prognostic indicators in COVID-19 be assistance management disease, instances that are critical or severe. purpose this study was investigate hematological inflammatory patients who were hospitalized determine how closely those markers associated severity condition. Materials Methods: In cross-sectional prospective analysis, there total 200 diagnosed COVID-19. demographic information comorbidities gathered through direct questioning. complete blood count recorded for every patient. addition, tests performed on D-dimer, ferritin, erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), C reactive protein (CRP). Systemic immune inflammation index (SII) calculated. association laboratory parameters patient’s outcome evaluated. Results: After 30-day follow-up, 32 (16%) out required ICU hospitalization, eight them (4%) dying. Each following od diabetes (OR=4.2; 95 % CI= 1.8-2291, p=0.021), hypertension (OR=3.1, CI=1.21-19.11, p=0.033), D-dimmer (OR=3.22, CI=1.43-9.12, p=0.037), ferritin (OR=2.18, CI=1.4-7.22, p=0.027), NLR (OR=3.26, 95% CI=1.5-7.18, p= 0.023), LDH (OR= 6.23, CI=1.77-22.9, p=0.034), CRP (OR=4.56, CI=1.32-28.85, p=0.007), independent risk factors Conclusion: hypertension, as well levels serum NLR, LDH, CRP, could utilized predict outcome.